ʻO nā lako hana maikaʻi, hui kūʻai ʻoihana, a ʻoi aku ka maikaʻi ma hope o nā lawelawe kūʻai; He ʻohana nui hoʻi mākou, pili nā mea a pau i ka waiwai o ka hui "hoʻohui, hoʻolaʻa, hoʻomanawanui" no ka minipig-pbmc,Puʻuwai Tissue kit, pahu cyp2c8, Puke Tissue Endothelium, Kiko Tissue Spleen. ʻO kā mākou kumu ʻo "kūʻai kūpono, ka manawa hana hoʻokele waiwai a me ka lawelawe maikaʻi loa" Manaʻo mākou e hui pū me nā mea kūʻai nui aku no ka hoʻonui ʻana a me nā pono. I kēia manawa, ke manaʻo nei mākou e hoʻomohala i kahi hui ʻoihana honua, ke kakali nei mākou i ka loaʻa ʻana o nā makana no nā ʻoihana hui a me nā papahana hui ʻē aʻe.ugt2b15, nā hakina S9 o ka ʻōpū, puʻupuʻu cell B kanaka, kiʻi ʻiʻo thymus.
ʻO Micronuclei nā chromatids holoʻokoʻa a i ʻole nā ʻāpana acentric a i ʻole nā chromosomes apo e mau ana i loko o ka cytoplasm ke komo mau nā chromosomes i nā keena kaikamahine e hana i ka nuclei ma hope o ka mitosis.
I kēia mau lā, ua kākau ʻo IPHASE, me ka Perelman School of Medicine ma ke Kulanui o Pennsylvania, i kahi ʻatikala ma ka puke pai Antibody Therapeutics (IF=4.56) i kapa ʻia "Development of a
Ma ke kahua ākea o ka lāʻau lapaʻau a me ka ʻike ʻana i ka lāʻau, ua hoʻokumu ʻo IPHASE i kahi pūʻulu o nā kit biomicrosomes kiʻekiʻe-performance, me ka kit microsomes ate, kit microsomes intestinal a me nā micros intestinal.
Ma muli o ka emi ʻana o ka hana o ka enzyme metabolizing i ka lāʻau me ka hoʻolōʻihi ʻia o ka manawa incubation in vitro, loaʻa i nā hiʻohiʻona kuʻuna in vitro metabolism nā palena e like me ka manawa incubation pōkole.
ʻO Antibody-Drug Conjugate (ADC) kahi ʻano hou o ka lāʻau biotechnology e hui pū ana i nā pūhui therapeutic mole liʻiliʻi i ka huli ʻana i nā antibodies / ʻāpana antibody e nā loulou.
Loaʻa i ka hale hana nā mea hana kiʻekiʻe, nā limahana akamai a me ka pae hoʻokele maikaʻi, no laila ua hōʻoia ka maikaʻi o ka huahana, ʻoluʻolu a hauʻoli kēia hui!